Prevalence of occult hepatitis C virus among hemodialysis patients in Tanta university hospitals: a single-center study

被引:0
作者
Ghada Abdelmoemen
Samy Abdelkader Khodeir
Sabry Abou- Saif
Abdelrahman Kobtan
Sherief Abd-Elsalam
机构
[1] Tanta University,Department of Clinical Pathology, Faculty of Medicine
[2] Tanta University,Department of Internal Medicine, Faculty of Medicine
[3] Tanta University,Department of Tropical Medicine, Faculty of Medicine
[4] Tanta University Hospital,Tropical Medicine Department
来源
Environmental Science and Pollution Research | 2018年 / 25卷
关键词
Occult hepatitis C; HCV; PBMCs; Peripheral blood mononuclear cells; Prevalence; Hemodialysis; HCV RNA; Anti-HCV;
D O I
暂无
中图分类号
学科分类号
摘要
Occult hepatitis C virus infection (OCI) is a newly defined type of infection by the chronic hepatitis virus (HCV) distinguished by the existence of HCV RNA in liver tissue and/or peripheral blood mononuclear cells (PBMCs) in patients whose plasma are devoid of both positive serology and RNA. Patients on maintenance hemodialysis evince a higher HCV prevalence than the general population due to high nosocomial transmission by the dialysis units. We investigated the prevalence of occult HCV infection in patients attending our university hemodialysis centers for maintenance hemodialysis. Sixty-two CHD patients negative for serum HCV tests were enrolled in the study. PMNCs were tested by real-time PCR for the presence of HCV RNA. For the 62 patients, the average duration since starting dialysis was 32.7 months and the mean (SD) alanine transaminase and aspartate transaminase were 25.74 ± 9.75 and 28.81 ± 11.32 IU/l, respectively. Out of the 62 CHD patients negative for serum anti-HCV and HCV RNA patients, only three (4.84%) were shown to have HCV RNA in their PBMCs implying the diagnosis of OCI; their viral load range was 1.24–4.15 IU/ml. All three OCI-proven patients gave no history of hepatic disease. In this study, we found that patients considered to be free of HCV can have HCV replicating in their PBMCs. This awareness points to the possibility of HCV being transmitted from apparently uninfected persons. A positive HCV RNA detection in PBMCs is dependable in determining OCI among high-risk subjects particularly when a liver biopsy is not an option. HCV transmission can occur through hemodialysis units signaling incorrect application of infection control measures in our Egyptian dialysis units. Additional studies on hemodialysis patients are necessary to realize the true magnitude of OCI among this patient group and to highlight the importance of incorporating HCV viral assays in PBMCs into the diagnostic algorithm.
引用
收藏
页码:5459 / 5464
页数:5
相关论文
共 208 条
[1]  
Abdel-Moneim AS(2012)HCV infection among Saudi population: high prevalence of genotype 4 and increased rate of viral clearance PLoS One 7 e29781-1393
[2]  
Bamaga MS(2016)Occult hepatitis C Virus infection among Egyptian hemodialysis patients J Med Virol 88 1388-100
[3]  
Abu-Elsaad AS(2017)Efficacy of sofosbuvir plus ribavirin with or without peginterferon-alfa in treatment of a cohort of Egyptian patients with hepatitis C virus infection Infect Disord Drug Targets 17 95-131
[4]  
Shehab GM(1995)The prevalence of hepatitis C virus antibodies among hemodialysis patients in Jeddah area, Saudi Arabia Saudi J Kidney Dis Transpl. 6 128-933
[5]  
Farahat FM(2014)Prevalence of occult hepatitis C infection in chronic hemodialysis and kidney transplant patients J Hepatol 60 928-134
[6]  
Abdelrahim S(2003)Decrease in the hepatitis C virus (HCV) prevalence in hemodialysis patients in Spain: effect of time, initiating HCV prevalence studies and adoption of isolation measures Antivir Res 60 129-2292
[7]  
Khairy R(2008)Occult hepatitis C virus infection among hemodialysis patients J Am SocNephrol 19 2288-2292
[8]  
Esmail M(2008)Occult hepatitis C virus infection among hemodialysis patients J Am Soc Nephrol 19 2288-135
[9]  
Ragab M(1995)Prevalence of hepatitis C virus antibodies in hemodialysis patients in Madinah Al-Munawarah Saudi J Kidney Dis Transpl 6 132-176
[10]  
Abdel-Hamid M(2016)Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study Lancet Gastroenterol Hepatol 2 161-995